Daniel Lang
Pres Cell Therapy, VP Corp Dev, Athenex, Inc.
Companies
- Athenex, Inc.Pres Cell Therapy, VP Corp Dev Dec 1, 2021 to Sep 19, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Athenex, Inc.81,590 shares2Sep 16, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2022Shares withheld for tax 4,323 shares at $0.41 of Athenex, Inc.2
- Sep 16, 2022Exercised options 12,500 shares of Athenex, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2